Structural and molecular bases of angiotensin-converting enzyme inhibition by bovine casein-derived peptides: an in silico molecular dynamics approach

被引:4
|
作者
De Oliveira, Thomas Valente [1 ]
Guimaraes, Ana Paula [2 ]
Bressan, Gustavo Costa [3 ]
Maia, Elaine Rose [4 ]
dos Reis Coimbra, Jane Selia [1 ]
Poleto, Marcelo Depolo [5 ]
De Oliveira, Eduardo Basilio [1 ]
机构
[1] Univ Fed Vicosa, DTA, Vicosa, MG, Brazil
[2] Univ Fed Vicosa, Dept Quim DEQ, Vicosa, MG, Brazil
[3] Univ Fed Vicosa, Dept Bioquim & Biol Mol DBB, Vicosa, MG, Brazil
[4] Univ Brasilia, Inst Quim, LEEM, Brasilia, DF, Brazil
[5] Univ Fed Vicosa, DBG, Vicosa, MG, Brazil
关键词
Angiotensin-converting enzyme inhibition; anti-hypertensive compounds; casein-derived bioactive peptides; PROTEIN BIOCHEMICAL-CHARACTERIZATION; ACE; IDENTIFICATION; DOCKING; ANTIOXIDANT; BINDING; LISINOPRIL; HYDROLYSIS; MECHANISM; SYSTEM;
D O I
10.1080/07391102.2020.1730243
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The angiotensin-converting enzyme (ACE) plays a key role in blood pressure regulation process, and its inhibition is one the main drug targets for the treatment of hypertension. Though various peptides from milk proteins are well-known for their ACE-inhibitory capacity, research devoted to understand the molecular bases of such property remain scarce, specifically for such peptides. Therefore, in this work, computational molecular docking and molecular dynamics calculations were performed to enlighten the intermolecular interactions involved in ACE inhibition by six different casein-derived peptides (FFVAPFPEVFGK, FALPQYLK, ALNEINQFYQK, YLGYLEQLLR, HQGLPQEVLNENLLR and NAVPITPTLNR). Two top ranked docking poses for each peptide (one with N- and the other C-terminal peptide extremity oriented towards the ACE active site) were selected for dynamic simulations (50 ns; GROMOS53A6 force field), and the results were correlated to in vitro ACE inhibition capacity. Two molecular features appeared to be essential for peptides to present high ACE inhibition capacity in vitro: i) to interact with the S1 active site residues (Ala354, Glu384, and Tyr523) by hydrogen bonds; ii) to interact with Zn2+ coordinated residues (His383, His387, and Glu411) by short-lenght hydrogen bonds, as observed in the cases of ALNEINQFYQK (IACE = 80.7%), NAVPITPTLNR (IACE = 80.7%), and FALPQYLK (IACE = 79.0%). Regardless of the temporal stability of these strong interactions, they promoted some disruption of Zn2+ tetrahedral coordination during the molecular dynamics trajectories, and were pointed as the main reason for the greatest ACE inhibition by these peptides. On the other hand, peptides with intermediate inhibition capacity (50% < I-ACE < 45%) interacted mainly by weaker interactions (e.g.: electrostatic and hydrophobic) with the Zn2+ coordinated residues, and were not able to change significantly its tetrahedral coordination structure. These findings may: i) assist the discrimination in silico of "good" and "bad" ACE-inhibitory peptides from other food sources, and/or ii) to aid in designing de novo new molecules with ACE-inhibitory capacity. Communicated by Ramaswamy Sarma
引用
收藏
页码:1386 / 1403
页数:18
相关论文
共 50 条
  • [11] Insight into the binding of ACE-inhibitory peptides to angiotensin-converting enzyme: a molecular simulation
    Jiang, Zhenyan
    Zhang, Hansi
    Bian, Xuefeng
    Li, Jingfeng
    Li, Jing
    Zhang, Hui
    MOLECULAR SIMULATION, 2019, 45 (03) : 215 - 222
  • [12] Angiotensin-converting enzyme inhibition, antioxidant activity and cytotoxicity of bioactive peptides from fermented bovine colostrum
    Gaspar-Pintiliescu, Alexandra
    Oancea, Anca
    Cotarlet, Mihaela
    Vasile, Aida Mihaela
    Bahrim, Gabriela Elena
    Shaposhnikov, Sergey
    Craciunescu, Oana
    Oprita, Elena Iulia
    INTERNATIONAL JOURNAL OF DAIRY TECHNOLOGY, 2020, 73 (01) : 108 - 116
  • [13] In vitro and in silico inhibition of angiotensin-converting enzyme by carbohydrates and cyclitols
    Endringer, Denise C.
    Oliveira, Osmair V.
    Braga, Fernao C.
    CHEMICAL PAPERS, 2014, 68 (01) : 37 - 45
  • [14] Molecular mechanism of the interactions between inhibitory tripeptides and angiotensin-converting enzyme
    Zhou, Min
    Du, Kun
    Ji, Peijun
    Feng, Wei
    BIOPHYSICAL CHEMISTRY, 2012, 168 : 60 - 66
  • [15] Molecular interactions, bioavailability, and cellular mechanisms of angiotensin-converting enzyme inhibitory peptides
    Fan, Hongbing
    Liao, Wang
    Wu, Jianping
    JOURNAL OF FOOD BIOCHEMISTRY, 2019, 43 (01)
  • [16] Stability and cytotoxicity of angiotensin-I-converting enzyme inhibitory peptides derived from bovine casein
    Wu, Wei
    Yu, Pan-pan
    Zhang, Feng-yang
    Che, Hong-xia
    Jiang, Zhan-mei
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2014, 15 (02): : 143 - 152
  • [17] Food-derived Bioactive Peptides with Angiotensin-Converting Enzyme Inhibiting Effect: A Systematic Review
    Daza-Rodriguez, Belen
    Martinez, Angie Rodriguez
    Padilla, Albeiro Marrugo
    Lazaro, Johana Marquez
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2023, 14 (01) : 14 - 24
  • [18] Activity Prediction and Molecular Mechanism of Bovine Blood Derived Angiotensin I-Converting Enzyme Inhibitory Peptides
    Zhang, Ting
    Nie, Shaoping
    Liu, Boqun
    Yu, Yiding
    Zhang, Yan
    Liu, Jingbo
    PLOS ONE, 2015, 10 (03):
  • [19] Radiotracers for Molecular Imaging of Angiotensin-Converting Enzyme 2
    Xu, Wenqi
    Langhans, Sigrid A.
    Johnson, David K.
    Stauff, Erik
    Kandula, Vinay V. R.
    Kecskemethy, Heidi H.
    Averill, Lauren W.
    Yue, Xuyi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [20] Structural and molecular basis of angiotensin-converting enzyme by computational modeling: Insights into the mechanisms of different inhibitors
    Fang, Li
    Geng, Mingxian
    Liu, Chunlei
    Wang, Ji
    Min, Weihong
    Liu, Jingsheng
    PLOS ONE, 2019, 14 (04):